Asset
PAMIPARIB
BeOne Medicines Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03575065 | phase2 | completed | 2018-06-22 | 2020-10-09 | BeiGene | Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China |
| NCT02361723 | phase1 | completed | 2014-07-03 | 2019-09-03 | BeiGene | Phase 1a/1b BGB-290 for Advanced Solid Tumors. |
FDA applications (0)
This company has no applications containing this asset.